Healthcare organisations are facing the simultaneous pressures of demonstrating ROI on AI investments, addressing clinician burnout, and satisfying compliance requirements. In a new pharmaphorum ...
This year's Nobel Prize in Physiology or Medicine has been awarded to three scientists for their work on regulatory T cells (Tregs), research that has fuelled a well-stocked pipeline of potential new ...
UK-based Ignota Labs has acquired all of the clinical-stage assets in Kronos Bio's pipeline, after the US company ceased operations earlier this year. Ignota specialises in turning around promising ...
Last year, Idorsia Pharma claimed FDA approval for Tryvio (aprocitentan) as the first endothelin receptor antagonist for resistant hypertension, adding to the well-established treatment options for ...
Radiopharmaceuticals have rapidly evolved from a specialised therapeutic niche into a cornerstone of modern oncology. By combining molecular targeting with controlled radiation delivery, they add a ...
While advances in drug development have accelerated dramatically in recent years, pharmaceutical manufacturing processes have struggled to keep pace – for a number of intertwined reasons. And AI ...
Roche's entry into the category with afimkibart (RG6631) stemmed from its purchase of Telavant for $7.1 billion, and since then it has advanced the drug into a phase 3 programme, also in inflammatory ...
Trump called for the MMR vaccine – a pillar of childhood immunisation that protects against measles, mumps, and rubella (whooping cough) – to be broken up into three shots given separately in a Truth ...
Scotland was held up as proof that new models of adoption, AI-enabled diagnostics, and genomics can transform care at pace. But equally forceful were the warnings from industry executives: without ...
Privosegtor is Oculis ' second ophthalmic drug to start a pivotal trials programme after OCS-01, a topical anti-TNF drug in an eyedrop formulation, which is in a pair of phase 3 trials in patients ...
The algorithm will be added to Roche's navify library of clinical decision-making algorithms and other digital health technologies (DHTs), designed to assist healthcare systems in delivering faster ...
The AI Structural Biology (AISB) consortium was set up earlier this year to fine-tune OpenFold3, which is being developed by Mohammed AlQuraishi's team at Columbia University, with AbbVie and Johnson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback